GLPwatch
Trials (2167)
Page 21 of 37.
- The Effects of Exenatide After Gastric Restriction
- Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
- Antiproteinuric Effects of Liraglutide Treatment
- Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice
- Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
- Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
- Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
- Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
- Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
- The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers
- A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies
- Use of a GLP-1R Agonist to Treat Opioid Use Disorder
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
- Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
- Efficacy of Liraglutide Therapy in Patients With IPAA
- Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
- Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
- GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
- Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
- 24-h Energy Expenditure and Anti-obesity Medication
- Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
- A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range
- Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
- Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
- Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
- Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
- A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
- PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
- Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
- A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects
- A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
- Protein Supplementation Intervention on Body Weight
- A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
- Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
- A Phase 3 Study of HS-20094 in Patients With T2DM
- A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
- Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity
- Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
- An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
- A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
- Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
- Intravenous Exenatide (Byetta) During Surgery
- Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients
- Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes
- A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Liraglutide Hospital Discharge Trial
- Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
- Human Bioequivalence Test of Liraglutide Injection
- Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
- A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
- Effect of Liraglutide on Heart Frequency in Healthy Volunteers
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906